Takeda Pharmaceutical Company Limited (TKPHF)
OTCMKTS · Delayed Price · Currency is USD
30.90
+0.50 (1.64%)
Sep 11, 2025, 10:26 AM EDT
TKPHF Market Cap
TKPHF has a market cap or net worth of $47.48 billion as of September 12, 2025. Its market cap has increased by 0.10% in one year.
Market Cap
47.48B
Enterprise Value
79.22B
Revenue
31.05B
Ranking
n/a
PE Ratio
50.02
Stock Price
$30.90
Market Cap Chart
Since January 14, 1992, TKPHF's market cap has increased from 8.47B to 47.48B, an increase of 460.39%. That is a compound annual growth rate of 5.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 47.48B | 12.58% |
| Dec 30, 2024 | 42.17B | -6.54% |
| Dec 29, 2023 | 45.12B | -6.90% |
| Dec 30, 2022 | 48.46B | 14.20% |
| Dec 30, 2021 | 42.44B | -25.32% |
| Dec 30, 2020 | 56.83B | -8.34% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 781.22M |
| Elite Pharmaceuticals | 736.80M |
| Tian'an Technology Group | 732.84M |
| Glass House Brands | 585.86M |
| CytoDyn | 397.50M |
| Northwest Biotherapeutics | 380.94M |
| American Oncology Network | 346.29M |